Nubeqa 300 mg Tablet 16's

Nubeqa 300 mg Tablet 16's belongs to a group of medicines known as androgen receptor inhibitors. It is used to treat non-metastatic castration-resistant prostate cancer and metastatic hormone-sensitive prostate cancer (mHSPC) in combination with docetaxel. Non-metastatic castration-resistant prostate cancer (nmCRPC) is prostate cancer that has not spread but continues to grow despite low testosterone levels. Metastatic hormone-sensitive prostate cancer (mHSPC) is a cancer that has spread to other parts of the body but still responds to testosterone-lowering treatments.

Nubeqa 300 mg Tablet 16's contains Darolutamide, which works by inhibiting the effects of androgens, the hormones that promote prostate cancer growth. By blocking androgen stimulation, Nubeqa 300 mg Tablet 16's helps slow the progression of cancer and limits its spread.

Take Nubeqa 300 mg Tablet 16's for the duration prescribed by your doctor based on your medical condition. Some common side effects may include abnormal liver function test, decreased white blood cell count (neutropenia), tiredness, pain in your arms, hands, legs, or feet, and rash. These effects are usually temporary and do not require medical attention. However, if they continue or worsen, see your doctor for advice.

Nubeqa 300 mg Tablet 16's is for use in men only. Pregnant women should not take this medication as it may harm the fetus. Before taking Nubeqa 300 mg Tablet 16's, inform your healthcare provider about any medical conditions you have, including heart problems, high blood pressure, diabetes, high cholesterol levels, seizures, brain injury, stroke, brain tumors, or any kidney or liver problems. Nubeqa 300 mg Tablet 16's may reduce male fertility and affect the ability to father children. Talk to your doctor if you have concerns regarding fertility.

• Nubeqa 300 mg Tablet 16's can be taken with food.
• Nubeqa 300 mg Tablet 16's is usually taken twice a day, or as prescribed by your doctor.
• Swallow Nubeqa 300 mg Tablet 16's as a whole with a glass of water.
• Do not break, crush or chew it.

Nubeqa 300 mg Tablet 16's contains darolutamide, an androgen receptor inhibitor. It is used to treat non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC). Most prostate cancers need testosterone to grow, and in men, the testicles are the main source of testosterone production. Nubeqa 300 mg Tablet 16's works by inhibiting androgen receptors, preventing testosterone from stimulating cancer cell growth and slowing down the spread of prostate cancer.

Do not take Nubeqa 300 mg Tablet 16's if you are allergic or hypersensitive to any of its components. Before taking Nubeqa 300 mg Tablet 16's, inform your healthcare provider about any medical conditions you have, including heart problems, high blood pressure, diabetes, high cholesterol levels, seizures, brain injury, stroke, brain tumors, or any kidney or liver problems. Pregnant women should not take this medication as it may harm the fetus. If taken during pregnancy, consult a doctor immediately. Nubeqa 300 mg Tablet 16's is for use in men only; it is not recommended for use in female patients and children.